Abstract
Because of its large prevalence and association with higher cardiovascular (CV) risk, prehypertension negatively affects public health. Prehypertension starts as a minor blood pressure (BP) elevation in childhood and young adulthood. Thereafter, BP in the prehypertension group increases steeply. This BP acceleration is associated with the restructuring of resistance arteries. In rats with spontaneous hypertension (SHR) and in humans, lowering BP with drugs that act on the renin–angiotensin system reverses arteriolar changes. In SHR, a short period of early treatment prevented subsequent accelerated hypertension. We investigated whether in prehypertension a period of treatment may postpone the development of hypertension. Two years after discontinuation of treatment, there was a modest suppression of new hypertension. Guidelines suggest lifestyle modifications for the management of prehypertension, but treatment can be initiated in patients with additional CV risk factors.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Robinson SC, Brucer M (1939) Range of normal blood pressure. A statistical and clinical study of 11,383 persons. Arch Intern Med 64:409–444
Julius S, Schork MA (1971) Borderline hypertension–a critical review. J Chronic Dis 23:723–754
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure (1997) Arch Intern Med 157:2413–2446
1993 guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting (1993) J Hypertens 11:905–918
Mancia G, De Backer G, Dominiczak A et al (2007) 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25:1105–1187
Chobanian AV, Bakris GL, Black HR et al (2003) The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289:2560–2572
Neaton JD, Kuller, L, Stamler, J et al (1995) Impact of systolic and diastolic blood pressure on cardiovascular mortality. In: Laragh JH, Brenner, BM (eds) Hypertension. Pathophysiology, diagnosis and management, vol 1, 2nd edn. Raven Press Ltd New York, pp 127–144
Egan BM, Julius S (2008) Prehypertension: risk stratification and management considerations. Curr Hypertens Rep 10:359–366
Julius S, Nesbitt SD, Egan BM et al (2006) Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 354:1685–1697
Mancia G, Facchetti R, Bombelli M et al (2006) Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 47:846–853
Sega R, Trocino G, Lanzarotti A et al (2001) Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation 104:1385–1392
Pierdomenico SD, Cuccurullo F (2011) Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens 24:52–58
Julius S, Jamerson K, Mejia A et al (1990) The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh blood pressure study. JAMA 264:354–358
Palatini P, Julius S (1997) Heart rate and the cardiovascular risk. J Hypertens 15:3–17
Julius S, Pascual AV, Reilly K et al (1971) Abnormalities of plasma volume in borderline hypertension. Arch Intern Med 127:116–119
Smith S, Julius J, Jamerson K (1994) Hemotocrit levels and physiologic factors in relationship to cardiovascular risk in Tecumseh, Michigan. J Hypertens 12:455–462
Nesbitt SD, Julius S, Leonard D et al (2005) For the TROPHY study investigators is low-risk hypertension fact or fiction? Am J Hypertens 18:980–985
Chen X, Wang Y (2008) Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis. Circulation 117:3171–3180
Tirosh A, Afek A, Rudich A et al (2010) Progression of normotensive adolescents to hypertensive adults: a study of 26,980 teenagers. Hypertension 56:203–209
London GM, Safar ME, Sassard JE et al (1984) Renal and systemic hemodynamics in sustained essential hypertension. Hypertension 6:743–754
Wong TY, Shankar A, Klein R et al (2004) Prospective cohort study of retinal vessel diameters and risk of hypertension. BMJ 329:79
Mulvany MJ (2003) Structural abnormalities of the resistance vasculature in hypertension. J Vasc Res 40:558–560
Folkow B (1987) Structure and function of the arteries in hypertension. Am Heart J 114:938–948
Furuyama M (1962) Histometrical investigations of arteries in reference to arterial hypertension. Tohoku J Exp Med 76:388–414
Short D (1966) Morphology of the intestinal arterioles in chronic human hypertension. Br Heart J 28:184–192
Heagerty AM, Aalkjaer C, Bund SJ et al (1993) Small artery structure in hypertension. Dual processes of remodeling and growth. Hypertension 21:391–397
Mulvany MJ, Aalkjaer C (1990) Structure and function of small arteries. Physiol Rev 70:921–961
Egan B, Panis R, Hinderliter A et al (1987) Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest 80:812–817
Panza JA, Casino PR, Kilcoyne CM et al (1993) Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 87:1468–1474
Harrap SB, Van der Merwe WM, Griffin SA et al (1990) Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension 16:603–614
Nakaya H, Sasamura H, Hayashi M et al (2001) Temporary treatment of prepubescent rats with angiotensin inhibitors suppresses the development of hypertensive nephrosclerosis. J Am Soc Nephrol 12:659–666
Schiffrin EL (2004) Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 17:1192–1200
Williams B, Lacy PS, Thom SM et al (2006) Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the conduit artery function evaluation (CAFE) study. Circulation 113:1213–1225
Julius S, Pascual AV, Sannerstedt R et al (1971) Relationship between cardiac output and peripheral resistance in borderline hypertension. Circulation 43:382–390
Flaa A, Eide IK, Kjeldsen SE et al (2008) Sympathoadrenal stress reactivity is a predictor of future blood pressure: an 18-year follow-up study. Hypertension 52:336–341
Cowley AW Jr, Liard JF, Guyton AC (1973) Role of baroreceptor reflex in daily control of arterial blood pressure and other variables in dogs. Circ Res 32:564–576
Julius S, Li Y, Brant D et al (1989) Neurogenic pressor episodes fail to cause hypertension, but do induce cardiac hypertrophy. Hypertension 13:422–429
Appel LJ, Moore TJ, Obarzanek E et al (1997) A clinical trial of the effects of dietary patterns on blood pressure. DASH collaborative research group. N Engl J Med 336:1117–1124
Appel LJ, Champagne CM, Harsha DW et al (2003) Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 289:2083–2093
Appel LJ, Clark JM, Yeh HC et al (2011) Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med 365:1959–1968
Julius S, Kaciroti N, Egan BM et al (2008) TROPHY study: Outcomes based on the seventh report of the Joint National Committee on Hypertension definition of hypertension. J Am Soc Hypertens 2:39–43
Luders S, Schrader J, Berger J et al (2008) The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure. J Hypertens 26:1487–1496
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this chapter
Cite this chapter
Julius, S., Feldstein, C.A. (2012). Prehypertension: Definitions, Clinical Significance and Therapeutic Approaches—To Treat or not to Treat?. In: Berbari, A., Mancia, G. (eds) Special Issues in Hypertension. Springer, Milano. https://doi.org/10.1007/978-88-470-2601-8_1
Download citation
DOI: https://doi.org/10.1007/978-88-470-2601-8_1
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2600-1
Online ISBN: 978-88-470-2601-8
eBook Packages: MedicineMedicine (R0)